-
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (STTR) (R41/R42 Clinical Trial Not Allowed)
(PA-20-025)
National Institute of Mental Health
National Institute of General Medical Sciences
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
National Human Genome Research Institute
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Development of Highly Innovative Tools and Technology for Analysis of Single Cells (SBIR) (R43/R44 Clinical Trial Not Allowed)
(PA-20-047)
National Institute of Mental Health
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute of Dental and Craniofacial Research
National Institute of Environmental Health Sciences
National Eye Institute
National Human Genome Research Institute
National Center for Advancing Translational Sciences
National Center for Advancing Translational Sciences
Application Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
-
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)
(PAR-20-037)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
Application Receipt Date(s): Standard dates apply.
The first standard application due date for this FOA is February 5, 2020
-
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
(PAR-20-038)
National Institute of Mental Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
Application Receipt Date(s): Standard dates apply
The first standard application due date for this FOA is February 5, 2020.
-
Enhancing Regulatory Science for Advancing Pharmaceutical Quality and Manufacturing (U01) Clinical Trials Optional
(PAR-20-083)
Food and Drug Administration
Application Receipt Date(s): April 10, 2020, by 11:59 PM Eastern Time.
April 5, 2021, by 11:59 PM Eastern Time.
April 4, 2022, by 11:59 PM Eastern Time.
-
NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)
(PAR-20-084)
National Institute of Biomedical Imaging and Bioengineering
National Institute on Aging
Application Receipt Date(s): Standard dates apply.
-
Pilot Centers for Precision Disease Modeling (U54)(Clinical Trials Not Allowed)
(PAR-20-085)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): June 24, 2020
-
Infrastructure for the Expansion of Rhesus macaque Colonies to Support HIV/AIDS-related Research (C06 Clinical Trial Not Allowed)
(PAR-20-087)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): March 6, 2020.
All applications are due by 5:00 PM local time of applicant organization.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Digital, Limited Interaction Trials and Epidemiology (D-LITE): Targeting HIV Incidence in the United States (U01 Clinical Trial Required)
(RFA-AI-19-067)
National Institute of Allergy and Infectious Diseases
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Institute of Mental Health
Application Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Radiobiology of High Linear Energy Transfer (High LET) Exposure in Cancer Treatment (R01, Clinical Trial Not Allowed)
(RFA-CA-20-032)
National Cancer Institute
Application Receipt Date(s): March 19, 2020
-
Center for Collaborative Research on Complex Generics (U18) Clinical Trials Optional
(RFA-FD-20-007)
Food and Drug Administration
Application Receipt Date(s): April 13, 2020
-
Renewal - Investigation of impact of manufacturing difference and formulation variation on drug release for Levonorgestrel Intrauterine System (U01) Clinical Trials Not Allowed
(RFA-FD-20-020)
Food and Drug Administration
Application Receipt Date(s): New Date March 31, 2020, by 11:59 PM Eastern Time.
Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date.
Late applications will not be accepted for this FOA.
-
Animal and Biological Material Resource Centers (P40) (Clinical Trials Not-Allowed)
(RFA-OD-20-002)
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): January 7, 2023
-
MoTrPAc Phase 2 Animal Studies (U01 Clinical Trial Not Allowed)
(RFA-RM-20-009)
Office of Strategic Coordination (Common Fund)
Application Receipt Date(s): March 20, 2020